Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.

Source:http://linkedlifedata.com/resource/pubmed/id/9816195

Download in:

View as

General Info

PMID
9816195